These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9631606)

  • 1. A case of primary non-Hodgkin's lymphoma of the uterine cervix treated by combination chemotherapy (THP-COP).
    Nasu K; Yoshimatsu J; Urata K; Miyakawa I
    J Obstet Gynaecol Res; 1998 Apr; 24(2):157-60. PubMed ID: 9631606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
    Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report.
    Szánthó A; Bálega J Já; Csapó Z; Sréter L Lí; Matolcsy A; Papp Z
    Gynecol Oncol; 2003 Apr; 89(1):171-4. PubMed ID: 12694673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of primary hepatic lymphoma successfully treated by THP-COP therapy].
    Takauchi K; Kono H; Ito T; Zaima K; Okumoto S
    Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):65-8. PubMed ID: 12649851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
    Hara T; Yoshikawa T; Goto H; Sawada M; Yamada T; Fukuno K; Kasahara S; Shibata Y; Matsumoto T; Mabuchi R; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Nannya Y; Katsumura N; Takahashi T; Kito Y; Takami T; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
    Hematol Oncol; 2018 Oct; 36(4):638-644. PubMed ID: 29882279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
    Goto N; Tsurumi H; Goto H; Shimomura YI; Kasahara S; Hara T; Yasuda I; Shimizu M; Murakami N; Yoshikawa T; Fukuno K; Takahashi T; Kito Y; Takami T; Moriwaki H
    Ann Hematol; 2012 May; 91(5):705-714. PubMed ID: 22183251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal diffuse large B-cell lymphoma involving the uterine cervix.
    Ajakaiye A; Watson D; Abdelsalam H; Alalade A
    BMJ Case Rep; 2024 Jul; 17(7):. PubMed ID: 38977317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant lymphoma of the uterine cervix: a case report and review of literature.
    Biswal BM; Sharma A; Sharma MC; Prasad RR; Roy K; Rath GK
    J Indian Med Assoc; 1997 Jul; 95(7):434, 440. PubMed ID: 9425847
    [No Abstract]   [Full Text] [Related]  

  • 9. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
    Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
    Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.
    Cubo AM; Soto ZM; Cruz MÁ; Doyague MJ; Sancho V; Fraino A; Blanco Ó; Puig N; Alcoceba M; González M; Sayagués JM
    Medicine (Baltimore); 2017 May; 96(19):e6846. PubMed ID: 28489772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma.
    Tsurumi H; Hara T; Goto N; Kitagawa J; Kanemura N; Yoshikawa T; Kasahara S; Goto H; Fukuno K; Yamada T; Sawada M; Shimizu M; Takahashi T; Takami T; Moriwaki H
    Leuk Lymphoma; 2012 Feb; 53(2):247-53. PubMed ID: 21827339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Life-Threatening Hyponatremia by Chemotherapy in a Patient with Non-Hodgkin's Lymphoma].
    Morikawa G; Kinjo T; Hanaoka Y; Kiyono T; Okazawa K; Dan K
    Gan To Kagaku Ryoho; 2015 Dec; 42(13):2493-6. PubMed ID: 26809312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass.
    Ab Hamid S; Wastie ML
    Singapore Med J; 2008 Mar; 49(3):e73-5. PubMed ID: 18362991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
    Tsurumi H; Yamada T; Sawada M; Kasahara S; Kanemura N; Kojima Y; Fukuno K; Hara T; Saio M; Takahashi T; Oyama M; Ozawa K; Takami T; Moriwaki H
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):107-13. PubMed ID: 14648210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group study.
    Laver JH; Mahmoud H; Pick TE; Hutchinson RE; Weinstein HJ; Schwenn M; Weitzman S; Murphy SB; Ochoa S; Shuster JJ;
    Leuk Lymphoma; 2001 Jul; 42(3):399-405. PubMed ID: 11699405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Iijima K; Chizuka A
    Eur J Haematol; 2001 Jan; 66(1):24-30. PubMed ID: 11168504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly.
    Kitamura K; Takaku F
    Am J Clin Oncol; 1990; 13 Suppl 1():S15-9. PubMed ID: 2291455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
    Chubachi A; Miura AB; Yamaguchi A; Nishimura S
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2057-63. PubMed ID: 3293535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Testicular malignant lymphoma: a case report].
    Takeuchi Y; Sawada Y; Yabuki D; Masuda E; Satou D; Iwasawa T; Kuroda K; Tajima M; Matsushima M
    Hinyokika Kiyo; 2003 Nov; 49(11):675-8. PubMed ID: 14719457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review.
    Goda JS; Gaikwad U; Narayan A; Kurkure D; Yadav S; Khanna N; Jain H; Bagal B; Epari S; Singh P; Sengar M; Laskar S
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1264. PubMed ID: 32761885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.